SCHEDULE: Vanguard Group Divests Pulmonx Corp Stake

The Vanguard Group reported a 0% beneficial ownership in Pulmonx Corp following an internal realignment, indicating a full divestment of its previously held stake.

Summary

• The Vanguard Group filed an Amendment No. 3 to Schedule 13G for Pulmonx Corp.
• The filing reports 0% beneficial ownership of Pulmonx Corp Common Stock by The Vanguard Group.
• This change is due to an internal realignment within The Vanguard Group, Inc. on January 12, 2026.
• Certain subsidiaries or business divisions of The Vanguard Group, Inc. will now report beneficial ownership separately (on a disaggregated basis).
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over these disaggregated securities.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event for Pulmonx Corp, as the divestment by The Vanguard Group is explicitly attributed to an internal organizational realignment rather than a change in investment thesis regarding Pulmonx.

Future Outlook

The filing does not contain forward-looking statements or guidance for Pulmonx Corp. It focuses on a past change in ownership structure for The Vanguard Group.

Management Comments

• On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment.
• Certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release.
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.
• Securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities.

Industry Context

StockSavvy.ai notes that institutional ownership changes, especially from major players like The Vanguard Group, are closely watched by the market. While this filing indicates a complete divestment by the parent entity, the explanation points to an internal structural change rather than a strategic exit based on Pulmonx's performance. This suggests that the underlying investment strategies for Pulmonx shares may continue under different reporting entities within Vanguard's broader structure.

Comparison to Industry Standards

• This filing primarily concerns a change in reporting structure for a major institutional investor, The Vanguard Group, rather than a performance update for Pulmonx Corp. Therefore, direct comparisons to industry-standard company performance metrics or projects are not applicable.
• The realignment of reporting responsibilities within a large asset manager like Vanguard is a common practice for optimizing compliance and operational efficiency, similar to how BlackRock or State Street might adjust their internal reporting for various funds and divisions.

Stakeholder Impact

• Shareholders of Pulmonx Corp: May observe a change in institutional ownership data, but the underlying investment by Vanguard's broader entities might persist under different reporting.
• The Vanguard Group: Internal realignment impacts how beneficial ownership is reported across its various subsidiaries and business divisions.

Next Steps

• Subsidiaries or business divisions of The Vanguard Group, Inc. will report beneficial ownership separately for Pulmonx Corp.

Key Dates

Recommendation

The filing indicates a change in reporting structure for The Vanguard Group, not a strategic divestment based on Pulmonx Corp's fundamentals. While the parent entity now reports 0% ownership, the underlying investment may continue through other Vanguard subsidiaries. Therefore, this filing alone does not provide a basis for a 'buy' or 'sell' recommendation, warranting a 'hold' as investors await further fundamental news from Pulmonx Corp or new Schedule 13G filings from Vanguard's disaggregated entities.

Keywords

Pulmonx Corp, Vanguard Group, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, SEC Filing, Divestment, Realignment